Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 30951011" data-attributes="member: 562115">Yes ... but initially to test for safety, tolerability, side-effects and also to determine the correct dosage by measuring the immune response. PS: Previous animal studies may have shown that it's effective. The vaccine's unique four-virus platform distinguishes it from other oncolytic virus therapies currently in development in several countries.These viruses are engineered to perform a dual function: directly destroying malignant cells while simultaneously activating the patient's anti-tumor immune response. This dual mechanism aims to create a comprehensive anti-cancer effect that leverages both direct viral oncolysis and enhanced immune system activation.Personalised cancer vaccines are not cheap. In the West the costs can be in excess of $20K but in Russia it's said to cost 300K Rubles (about $3500)</blockquote>

Top Bottom